Objective: Whether older people living with HIV (PLWH) can achieve similar functional benefits with exercise as their uninfected peers and the ideal intensity of exercise needed for these benefits are not known.
Background
With a dramatic improvement in life expectancy, the majority of people living with HIV (PLWH) are now aged 50 years or older [1] . These older PLWH have an increased burden of age-related comorbidities, and, subsequently, impairments in physical function and the development of frailty [2] . Regular physical activity improves function in other older adult populations with multiple comorbidities and prevents functional decline in middle-aged and older adult populations [3, 4] . Similar to the general population, PLWH have high rates of sedentary behavior and low rates of regular physical activity, with a recent meta-analysis suggesting that only about one-half of PLWH meet recommended US Department of Health and Human Services (DHHS) physical activity guidelines of at least 150 minutes of moderate-intensity activity weekly [5, 6] . Moreover, the lowest rate of physical activity is found in older PLWH with the greatest burden of comorbidities [7] .
Endurance or resistance exercise interventions in PLWH support the safety and efficacy of exercise to improve cardiovascular, metabolic, and functional measures in younger PLWH [8, 9] . Extrapolating from these findings and from studies of older uninfected persons, some investigators have proposed the standard DHHS exercise guidelines for older PLWH, including a combination of endurance and resistance exercise three times per week [6, 10, 11] . Although meeting the standard DHHS guidelines for regular physical activity is sensible for most older adults, the added benefit or harm of high-intensity exercise in restoring and improving function in HIV has not been studied. For example, among older, frail adults, supervised high-intensity exercise appears as safe and may be more effective in improving functional and strength measures than low or moderate-intensity interventions [12, 13] .
Evaluation of high-intensity exercise in PLWH may be important, as this population appears to have greater impairment in cardiorespiratory capacity (as measured by maximal oxygen consumption, VO 2 max) across the agespectrum compared with age-matched uninfected controls [14] , with even greater impairments among older PLWH with non-AIDS comorbidities [15] . Underlying mitochondrial and skeletal muscle impairments, including impaired peripheral oxygen uptake [16] , impaired cardiac response to exercise [17] , or underlying impairments in oxygen diffusion capacity [18] , related to HIVor exposure to older antiretroviral therapy (ART), suggest that PLWH may require a different exercise dose to restore and achieve levels of cardiovascular fitness and physical function similar to HIV-uninfected peers. Conversely, these impairments may suggest greater difficulty in achieving or lower response to high compared with moderate-intensity exercise in older PLWH. To best inform the dose of exercise needed for maximal benefit in older PLWH, the goals of this study were to determine the impact of exercise on physical function and compare changes in physical function in response to two levels of exercise intensity among sedentary, older adults living with or without HIV infection.
Methods
The Exercise for Healthy Aging Study enrolled PLWH and HIV-uninfected controls from April 2014 to May 2017 (Clinical Trials NCT02404792). All participants were aged 50-75 years, sedentary (<60 min of physical activity each week for 6 months preceding by self-report), had a BMI between 20 and 40 kg/m 2 , and had no contraindications to initiating an exercise regimen (e.g. severe mobility limitation, unstable angina, supplemental oxygen requirement, uncontrolled hypertension). Participants with diabetes had hemoglobin A1c of 7.5% or less; sex hormone supplementation was restricted to stable, physiologic doses for at least 3 months prior to study entry, and intramuscular testosterone was excluded. PLWH were on stable ART with an undetectable HIV-1 RNA for more than 2 years and a CD4 þ T-cell count more than 200 cells/ml. The study procedures were approved by the Colorado Multiple Institutional Review Board. Written informed consent was obtained from all participants.
Study procedures
All participants underwent a graded, treadmill, cardiovascular stress test, and measurement of VO 2 . During an initial 5-min warm-up, walking speed was adjusted to elicit a heart rate (HR) $70% of age-predicated maximum HR. Speed was held constant and the grade of the treadmill was increased by 2% every 2 min until volitional exhaustion or until the test was stopped. Testing was terminated if any of the American College of Sports Medicine absolute (and, in some cases, relative) stopping criteria were met [11] . The O 2 and CO 2 content of expired air were measured continuously by open circuit spirometry and averaged every 30 s using an automated online system (TrueMax 2400; ParvoMedics, Sandy, Utah, USA). Objective evidence that VO 2 max was attained included at least two of the following: a plateau in VO 2 despite an increased energy demand, a respiratory exchange ratio in excess of 1.10, and a maximal HR within 10 beats of the age-predicted value. In the absence of these benchmarks, the maximum measured VO 2 was deemed VO 2 peak. All participants had to reach 85% of age-predicted maximum HR for cardiac risk assessment prior to proceeding to the exercise intervention. Abnormal test results required further evaluation and risk assessment per a cardiologist's recommendation prior to proceeding. Muscle strength was evaluated as the maximal weight that can be lifted only one time using correct lifting form through the full range of motion (1-repetition maximum, 1-RM).
Exercise intervention
Each participant attended supervised exercise sessions three times per week for 24 weeks at the University of Colorado-Anschutz Medical Campus Exercise Research Laboratory. Participants began with a 2-week supervised, low-intensity exercise acclimation for machine familiarization consisting of 20-30 min of treadmill walking at 30-40% of VO 2 max and three sets of eight repetitions of four weight-assisted machine (Cybex, Owatonna, Minnesota, USA) exercises (bench press, leg press, lateral pulldown, and a rotating 4th exercise) at low-intensity (40-50% of the 1-RM). After 2 weeks, participants increased cardiovascular endurance exercise intensity to 40-50% VO 2 max and time by 5 min every week to achieve a goal of 50 min/session by the end of 12 weeks. Resistance exercise was increased to 60-70% of 1-RM; 1-RM was reassessed every 3 weeks and target weight loads adjusted as needed. At week 12, VO 2 max measurements were repeated and participants were randomized to either continue moderate-intensity exercise or advance to high-intensity (60-70% of week 13 VO 2 max and >80% 1-RM) for the remaining 12 weeks. Adherence to the intervention was calculated as the number of attended exercise sessions divided by the number of expected exercise sessions.
Outcome measures
We used a modified version of the Short Physical Performance Battery (SPPB) [19] that improves discrimination of physical function at the higher end of the functional spectrum by using 10 repeat chair stands (increase from 5), a 4-m timed walk (usual speed), and a standing balance test for 30 s with a single-leg stand. Split times for the chair stand and standing balance test were obtained for calculation of the standard SPPB score. Additional functional outcomes were the time to complete a 400-m walk (400 MWT) and time to climb a flight of 10 stairs. Frailty was assessed using criteria established by Fried et al. [20] Weakness was assessed by the average of three dominant hand grip strength measurements and defined by applying previously defined sex and BMI cutoffs using a Jamar Dynamometer (Lafayette Instruments, Lafayette, Indiana, USA) [20] . Slowness was defined by the average of two readings on a 4-m walk: men 173 cm or less and women 159 cm or less in height requiring at least 6.22 s or men more than 173 cm and women more than 159 cm requiring at least 5.33 s to complete the walk met the criterion for slowness [20] . Weight loss at study entry was defined by self-report of an unintentional weight loss of at least 10 pounds during the past year. Low activity was defined as being 'limited a lot' in response to the Short Form-36 question, 'does your health limit you in vigorous activities such as running, lifting heavy objects, or participating in strenuous sports?'. Exhaustion was defined as experiencing at least three to four times per week feeling that 'everything I do is an effort' or 'sometimes I just cannot get going' from the Center for Epidemiologic Studies Depression scale. Participants were considered nonfrail if they met 0 components, prefrail if one or two components, and frail if three to five components were met. Repeat chair stands were measured every 2 weeks and 1-RM tests every 4 weeks. All other physical function measures and questionnaires were obtained prior to initiating exercise, at week 12, and at week 24 on a nonexercise day or prior to an exercise session.
Anticipated and unanticipated events were categorized as definitely, probably, possibly, or not related to the exercise intervention.
Statistical analyses
Study data were collected and managed using REDCap electronic data capture tools hosted at the University of Colorado and supported by Vanderbilt University, Nashville, Tennessee, USA [21] . The primary outcome was change from baseline in 10-time chair rise time. Additional outcomes, including differences by exercise intensity, were considered secondary. The randomization was balanced by HIV serostatus, sex, and age. Log transformations were performed due to right skew, as appropriate, and results reported as geometric means. Baseline measures were compared via t square and chisquare tests.
Primary predictors included HIV serostatus and randomized intensity. All linear and mixed models adjusted for baseline (or week 12). Adjusted models also included both age and BMI (selected a priori), and interactions between HIV serostatus, randomized intensity, and time, as appropriate. Kaplan-Meier estimation was utilized for time to event outcomes. Two-sided tests are reported assuming a 0.05 significance level. Outcomes were considered complementary and reported without adjustment for multiple comparisons [22, 23] . All relevant analyses are reported to allow a post-hoc adjustment. Analyses utilized R (v. 3.4.2; R Foundation for Statistical Computing, Vienna, Austria) and SAS (v.9.4; SAS Institute Inc., Cary, North Carolina, USA).
Results
A total of 89 PLWH and HIV-uninfected controls underwent screening and 69 participants began exercise (32 PLWH, 37 HIV-uninfected controls; Fig. 1 ). Baseline demographic characteristics participants are shown in Table 1 .
A majority of participants had 12 of 12 possible points on the SPPB (66% PLWH, 84% controls); three PLWH and one control had an SPPB score of 10 or less. Although no participants met criteria for frailty prior to exercise, 75% of PLWH (N ¼ 24) and 49% of controls (N ¼ 18) were prefrail. Weakness was the most common frailty criterion met (10 PLWH, nine controls) followed by exhaustion (nine PLWH, three controls) and low activity (six PLWH, eight controls). Compared with controls, PLWH had significantly poorer performance on time to rise from a chair 10 times, 400-MWT, stair climb, bench press, leg press, and lateral pull-down (Table 2) .
Physical function changes by HIV serostatus
Significant improvements in physical function were seen between weeks 0 and 12 and between weeks 13 and 24 in nearly all physical function measures, regardless of serostatus group (Fig. 2a Between baseline and week 24, eight PLWH and two controls had an improvement in SPPB score and no participants had a decline in SPPB score. Following 24 weeks of exercise, 13 PLHWand seven controls had fewer frailty criteria, and three PLWH and five controls had more frailty criteria than at baseline.
Physical function changes by exercise intensity Twenty-eight (13 PLWH, 15 controls) participants were randomized to continue moderate-intensity exercise and 31 (15 PLWH, 16 controls) to advance to high-intensity exercise. In secondary analyses, both moderate-intensity and high-intensity exercise groups experienced significant improvements between weeks 13 and 24 on 1-RM measures, 400-MWT, and chair stand time (Fig. 2b) . The high-intensity group tended to have greater percentage improvements in most functional outcomes; the only significant difference between these groups at 24 weeks was a faster 400-MWT among high-intensity exercisers. Similar results were seen in analyses further adjusted for age and BMI except the difference in 400-MTW no longer reached statistical significance (P ¼ 0.06; Supplemental Table 2 , http://links.lww.com/QAD/B350). Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
AIDS
Among high-intensity exercisers from weeks 13 to 24, five had an improvement in frailty score and none worsened, two had an improvement in SPPB score, and two had a decline. In contrast, one moderate intensity exerciser had fewer frailty criteria, whereas four met more frailty criteria; no moderate intensity exercisers had an improvement in SPPB score and one declined.
Changes in physical function by HIV serostatus and exercise intensity
In exploratory analyses, we assessed whether the effects of exercise intensity differed by HIV serostatus in measures repeated every 2-4 weeks (strength and chair rise) and outcomes assessed at weeks 0, 12, and 24 (VO 2 max, grip strength, stair climb, 400-MWT). The effect of the exercise intensity differed by HIV status in bench (P ¼ 0.011) and leg press (P ¼ 0.033), with a trend toward significant difference in lateral pulldown (P ¼ 0.056), Fig. 3 , Supplemental Table 3 , http:// links.lww.com/QAD/B350. Among PLWH, highintensity exercisers had significantly greater gains than moderate-intensity exercisers in bench and leg press strength (P ¼ 0.049 and 0.016, respectively). No significant differences in exercise intensity were detected among controls (all P ! 0.11). Among PLWH, both moderate and high-intensity groups had significant improvements in chair rise time, but the change did not differ by exercise intensity (P ¼ 0.32). In functional outcomes assessed only at weeks 0, 12, and 24, no significant interactions between HIVand exercise intensity were detected (Fig. 3) , but, for most outcomes, greater percentage improvements were found in PLWH who exercised at higher intensity compared with moderate intensity.
The number of prefrail participants decreased from weeks 12 to 24 among PLWH randomized to moderate (5 vs. 4) and high-intensity (11 vs. 8) exercise, and controls randomized to high-intensity (6 vs. 5) exercise, but increased among moderate-intensity control exercisers 5 versus 7). . Overall (weeks 0-24), the adherence was highest among PLWH randomized to moderate intensity (90.3%) and lowest among controls randomized to high intensity (82.7%); adherence was 87.5% in PLWH randomized to high-intensity and controls to moderate-intensity exercise.
Exercise adherence

Adverse events
From baseline to week 12, PLWH reported 12 related events (definitely, probably, or possibly) to the intervention, and five events that were unrelated; controls reported 10 related and two unrelated events. Events between weeks 1 and 12 included musculoskeletal (16), followed by dizziness (three), hypotension (one), shortness of breath (one), and hernia (one). Between weeks 13 and 24, PLWH reported 13 related and three unrelated events; controls reported two related and one unrelated event. Events were most commonly musculoskeletal (13) . Time to the first adverse event did not differ significantly by HIV serostatus (baseline to week 12; P ¼ 0.38), by exercise intensity (weeks 13-24; P ¼ 0.62), or by frailty group (baseline to week 12; P ¼ 0.22 and weeks 13-24; P ¼ 0.43).
Discussion
Regular physical activity is recommended for all older adults for the well described benefits on cardiovascular risk, obesity, diabetes, cancer, neurocognition, and physical function. Even among older adults with impaired physical function, moderate intensity exercise has been shown to delay the onset or reverse disability, as recently demonstrated in the large LIFE Trial [24] . As disability is increasingly more difficult to reverse with increasing impairment, returning older adults to the 'normal' functional curve is key to maintaining function. We have shown that among older, sedentary PLWH, greater impairments in many measures of baseline physical function can significantly improve with 6 months of endurance and resistance exercise. This is one of few studies to compare functional outcomes from the same exercise protocol in older adults living with HIV and uninfected controls of similar ages. Lastly, the comparisons of two levels of exercise intensity in a randomized clinical trial provide data to formulate exercise recommendations and guidelines for older adults living with HIV.
Although low-intensity or moderate-intensity exercise may have greater long-term adherence and patient acceptability, we hypothesized that a higher intensity exercise intervention would result in greater improvements in physical function within 6 months, delaying the onset of subsequent disability. Indeed, we found that both moderate-intensity and high-intensity exercise resulted in significant improvements in nearly all physical function outcomes, including improvements in SPPB components, decrease in the proportion of prefrail participants, and reduction in the number of frailty criteria. Not only were our participants adherent to the exercise regimen regardless of the intensity, PLWH randomized to higher intensity experienced significantly greater percentage improvement in measures of strength compared with those randomized to moderate-intensity, an intensity-effect not observed among controls. Although we were underpowered to detect an interaction between HIV serostatus and exercise intensity, we did detect a trend toward greater gains in response to highintensity exercise in PLWH.
To the best of our knowledge, no studies in the current ART era have compared the effects of exercise intensity on muscle strength, cardiovascular endurance, or physical function outcomes. Three pre or early ART era exercise interventions suggested a dose-response of exercise intensity on outcomes of strength and endurance [17, 25, 26] , although studies were small with poor retention, and participants were younger, many with AIDS, and most with either no ARTor with zidovudinebased regimens.
Most exercise interventions in PLWH have focused on strength and endurance outcomes among younger PLWH [27] , with few studies representative of the now majority of PLWH aged 50 and older experiencing multimorbidity and impairments in physical function. Recent Cochrane reviews of endurance and resistance exercise interventions among PLWH [8, 9] have highlighted a focus on strength, endurance, body composition, and immune function rather than physical function outcomes, with studies primarily focused on younger persons living with HIV. A pilot study of older men, all living with HIV, compared moderate (self-paced one mile walk) and high-intensity (up to 75-60% heart rate reserve) cardiovascular exercise over 16 weeks. Similar to our findings, the high-intensity group experienced significantly greater improvements, but on measures of exercise endurance rather than strength [28] .
In one of the only other studies focused on older adults [29] , a 12-month supervised, twice weekly resistance exercise intervention among adults 60 years or older living with or without HIV allowed self-selection of either light, moderate, or heavy intensity (with 12, 10, or eight repetitions per exercise, respectively). Both PLWH and controls had improvements in many functional measures. No comparison of the exercise intensity was provided [29] . A multidimensional 10-week center-based physiotherapy program that included moderate-to-vigorous endurance and resistance exercise, stretching, and goal setting found significantly improved physical function among 37 middle and older aged PLWH (mean age 51), but this study did not have an uninfected control group [30] .
Lower intensity or home-based interventions are often seen as more feasible interventions for larger scale implementation. A physical activity counseling intervention combined with an exercise prescription among PLWH aged 45 or older led to a 15% greater improvement in chair rise time and 5% greater improvement in 6-min walk distance compared with a nonexercising control group [31] . In comparison, our moderate to high-intensity exercise intervention led to an overall 30% improvement in chair rise time and 11% improvement in a comparable 400-MWT. In summary, low or moderate-intensity exercise interventions can lead to improvements in function, but results may be less pronounced than those seen with high-intensity exercise.
Whether the benefits of exercise among older, sedentary PLWH with prolonged ART exposure differ from the exercise effects among uninfected controls is not well understood or studied. Impairment in exercise capacity despite similar age and physical activity [14] , and impairments in mitochondrial function may mitigate the benefits of exercise when compared with uninfected controls [32] . Furthermore, underlying fatigue, neuropathy, substance abuse, and mood disorders that tend to be more prevalent among PLWH (as we saw) may limit the ability to achieve similar gains as uninfected controls in response to a standardized intervention. However, PLWH in our study achieved greater gains in physical function across multiple parameters, suggesting that HIV serostatus does not attenuate the effects of exercise on physical function.
Several strengths of our study should be highlighted. We included an uninfected control group of similar age, and a cohort of both PLWH and controls representative of a community-dwelling population in Colorado in regards to diversity and substance use. Nearly 90% of our participants completed the intervention, exercise adherence was similar in PLWH and controls, and the supervised center-based intervention provided greater standardization than unsupervised (e.g., home-based) interventions. Per DHHS guidelines, our intervention included both endurance and resistance exercise but was limited to 3 days/week, a feasible exercise goal for many older adults. Due to the intensive, center-based intervention, our recruitment was biased toward individuals that worked or lived near the research center and were able to commit to 6 months of exercise. These factors, in addition to limited hours of the research center and the targeted BMI range, may have limited the number of women we were able to enroll. Lastly, as highlighted on Table 1 , our PLWH differed from controls by many demographic characteristics and comorbidities. Due to our sample size, we were unable to account for many of these factors that may have also contributed to the exercise response (i.e. attenuated responses among smokers).
In summary, among sedentary, older adults, the effects of exercise on physical function are not attenuated among PLWH. Both moderate-intensity and high-intensity exercises result in significant improvements in physical function, endurance, and strength, and may delay the onset of disability and frailty. We found no reason to dissuade older PLWH from progressing to higher intensity exercise following several weeks of moderate-intensity training. Adherence to at least the recommended 150 minutes/week of moderate-intensity or 75 minutes/week of highintensity endurance exercise, and regular resistance exercise, should be encouraged for all older PLWH.
